Bilal Arif
Hoofd Techniek/Wetenschap/O&O bij SAREPTA THERAPEUTICS, INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Bilal Arif
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2022 | - |
| Corporate Officer/Principal | - | 31-12-2022 |
Loopbaan van Bilal Arif
Eerdere bekende functies van Bilal Arif
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2017 | 02-01-2019 |
Opleiding van Bilal Arif
| Tufts University | Graduate Degree |
| McGill University | Undergraduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Canada | 2 |
| Spanje | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Bilal Arif
- Ervaring
